This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts

Latest Highlights

EYLEA® (aflibercept) 8mg | Dosing
Discover dosing of EYLEA® (aflibercept) 8mg.
PP-EYL_8mg-IE-0159-1, January 2026
EYLEA® (aflibercept) 8mg | Resources
Discover some resources below that you can access to learn more about EYLEA 8mg in nAMD and DME.
PP-EYL_8mg-IE-0160-1, January 2026
EYLEA® (aflibercept) | Medical Information Contact
PP-PF-OPHT-IE-0025-1, December 2025

Ophthalmology Products

About EYLEA® (aflibercept) 8mg
Discover data and resources about EYLEA 8mg.
PP-EYL_8mg-IE-0150-1, January 2026

Ophthalmology Latest Resources

EYLEA® (aflibercept) 8mg | Downloadable Resources
Discover our HCP resources to learn more about EYLEA® (aflibercept) 8 mg
PP-EYL_8mg-IE-0162-1, December 2025

Ophthalmology On Demand & Webinars

EYLEA® (aflibercept) 8mg | Events & Webinars
Discover Events & On Demand Webinars below that you can access to learn more about EYLEA 8mg.
PP-EYL_8mg-IE-0161-1, January 2026